Chemical investigation of the stem bark of Turraeanthus africanus (Meliaceae) afforded a new pregnane derivative, 17α,20S-dihydroxypregn-4-ene-3,16-dione, named turraeasterodione, together with three known diterpenoids, methyl 14,15-epoxylabda-8(17),12E-dien-16-oate, 16-oxolabda-8(17),12E-dien-15-oic acid, and 16-acetoxy-12R,15-epoxylabda-8(17),13(16)-dien-15β-ol. Their structures were elucidated by spectroscopic and spectrometric methods. Methyl 14,,12E-dien-16-oate was found to exhibit anti-plasmodial activity against a chloroquine-resistant strain of Plasmodium falciparum.
Chemical studies of the Meliaceae have shown this family to be a rich source of tetranortriterpenoids [1, 2] . Steroids of the pregnane and stigmastane classes are also common in the Meliaceae [3] . Turraeanthus africanus (Welw. ex. C.D.C.) Pellegr. is a tree distributed in the tropical zone of Africa. It is usually found in dense stands in rain forests, along lakes and streams [4] . In Cameroon, the stem bark is used in the treatment of intestinal worms and malaria, and also by the Bakweris to stupefy fish. We recently reported the isolation and characterization of two labdane diterpenoids and a seco-tetranortriterpenoid from the seeds of T. africanus [5] . In continuation of our investigation of this species for new antiplasmodial agents, a pregnane derivative, and three known diterpenoids were isolated from the stem bark. The structural assignments, based on analysis of physical and spectral data, are reported herein.
Dried and powdered stem bark of T. africanus was extracted with CH 2 Cl 2 -MeOH (1:1). Evaporation in vacuo yielded a crude extract, a portion of which was subjected to silica gel chromatography and gel permeation chromatography over Sephadex LH-20 to afford a new steroid (1) and three known diterpenoids, methyl 14,15-epoxylabda-8(17),12Edien-16-oate (2) [6] , 16-oxolabda-8(17) ,12E-dien-15oic acid [7] , and 16-acetoxy-12R,15-epoxylabda-8(17),13(16)-dien-15β-ol [5] .
Compound 1 was obtained as white needles from n-hexane-EtOAc, mp 201-202 o C, [α] D -54.0 o . The molecular formula, C 21 H 30 O 4 , was deduced from the EIMS, which showed a molecular ion peak at m/z 346.50. In the IR spectrum, strong bands at ν max 3473, 3428, 1718 and 1658 cm -1 were indicative of two hydroxyl groups, one keto group and an α,βunsaturated carbonyl group, which was substantiated by the UV maximum absorbance at λ max 239 nm [8, 9] . The 13 C-NMR spectrum ( Table 1) (Figure 1 ). This also indicated that one of the hydroxyl groups was tertiary. A detailed analysis of the 1 H-1 H COSY spectrum in conjunction with the HMQC spectrum established the presence of several spin A single-crystal X-ray analysis performed on 1 (Figure 3 ) confirmed the proposed structure and also yielded the relative stereochemistry. On the basis of the above spectroscopic data, as well as by comparison with the data for the related compound, 20-hydroxypregn-4-ene-3,16-dione [10] , compound 1 was determined as 17α, 20S-dihydroxypregn-4-ene-3,16-dione, which was given the trivial name turraeasterodione. A solution of turraeasterodione (1) (30 mg) in pyridine (3 mL), and acetic anhydride (3 mL) was left at room temperature overnight. The reaction mixture was then extracted with toluene (3 x 10 mL) and evaporated to dryness. The residue was purified through a silica gel column, eluting with chloroform to yield 1a (32 mg).
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In vitro anti-plasmodial assay:
The in vitro antiplasmodial assays were performed using a modification of the semi-automated microdilution technique, described earlier [11] . The chloroquineresistant Plasmodium falciparum malarial parasite clone, F32, was utilised in susceptible tests. The tested compounds were dissolved in DMSO and serially diluted using malarial growth medium. Druginduced reduction in uptake of tritiated hypoxanthine was used as the index of inhibition of parasite growth. Chloroquine diphosphate was used as the positive control.
The most active compound (2) was tested for acute toxicity in vivo in 6 N C57 BL mice (approximately 20 g body weight). The volume of the stock solution of compound 2 equivalent to 60 μg/g body weight of mouse (2 x IC 50 ) was injected intraperitoneally into each of six mice. DMSO (0.25% per gram body weight) was also tested in another group of mice. The mice were provided with food and water the same as the control group of untreated mice and observed daily for seven days. This test was conducted in accordance with the European Community guidelines (EEC Directive of 1986; 86/609/EEC).
X-ray diffraction:
Crystals suitable for X-ray diffraction were obtained by recrystallization from n-hexane-EtOAc. A single crystal of suitable size (0.50 x 0.30 x 0.20 mm) was attached to a glass fibre using silicone grease and mounted on a goniometer head in a general position. Data were collected at 150 K on an Enraf-Nonius Kappa-CCD diffractometer, running under Nonius Collect software, and using graphite monochromated X-radiation. Precise unit cell dimensions were determined by post-refinement of the setting angles of a significant portion of the data using Scalepack [12] . The frame images were integrated using Denzo (SMN) [12] and the resultant raw intensity files processed using a locally modified version of DENZOX [13] . A semi-empirical absorption correction was applied [14] . Data were sorted and merged using SORTAV [15] . A total number of 13792 data points were collected, yielding 2271 unique data: hkl range -9 → +9, -13 → +13, -15 → +15.
The structure was solved by direct methods using SIR-97 [16] . All non-H atoms were allowed anisotropic thermal motion. C-H hydrogen atoms were included at calculated positions, with C-H =0.96 Å, and were refined with a riding model with U iso set to 1.2 times that of the attached C-atom. The O-H hydrogen atoms were found from difference maps and refined with a riding model. Refinement with SHELXL97-2 [17] , using full matrix least squares on F 2 and all unique data, converged to the residuals R [I > 2σ (I)] and Rw2 [I > 2σ (I)] of 0.0589 and 0.1142, respectively.
Supplementary material in the form of a CIF file has been deposited with deposition number CCDC 283679. These data can be obtained free of charge via www.ccdc.cam.ac.uk/data_request/cif, by emailing data_request@ccdc.cam.ac.uk, or by contacting The Cambridge Crystallographic Data Centre, 12, Union Road, Cambridge CB2 1EZ, UK; fax: +44 1223 336033.
